topicChokeberry Blood Pressure Meta-Analysis
claim1 1 2 3 Hypertension is a major global public health concern and the leading preventable risk factor for cardiovascular disease, stroke, and premature mortality [].
evidence level1
citationGuevara Guevara Eduardo Vladimir (2026)
sourceEffects of Oral Berry Supplementation on Blood Pressure in Adults with Hypertension or Elevated Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
topicChokeberry Blood Pressure Meta-Analysis
claimEven among clinical populations, participants with varying degrees of cardiovascular risk have been grouped together, including those with elevated blood pressure as well as other cardiometabolic conditions [], which may introduce additional heterogeneity due to differences in baseline risk and associated comorbidities.
evidence level1
citationGuevara Guevara Eduardo Vladimir (2026)
sourceEffects of Oral Berry Supplementation on Blood Pressure in Adults with Hypertension or Elevated Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
topicChokeberry Blood Pressure Meta-Analysis
claimTaken together, these factors contribute to variability in the findings and limit the applicability of existing evidence to individuals with elevated blood pressure or hypertension.
evidence level1
citationGuevara Guevara Eduardo Vladimir (2026)
sourceEffects of Oral Berry Supplementation on Blood Pressure in Adults with Hypertension or Elevated Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
topicChokeberry Blood Pressure Meta-Analysis
claimIt is estimated to affect more than one billion individuals worldwide, contributing substantially to the global burden of disease [,].
evidence level1
citationGuevara Guevara Eduardo Vladimir (2026)
sourceEffects of Oral Berry Supplementation on Blood Pressure in Adults with Hypertension or Elevated Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
topicChokeberry Blood Pressure Meta-Analysis
claimHowever, the evidence from randomized controlled trials (RCTs) remains inconclusive.
evidence level1
citationFrumuzachi O (2025)
sourceImpact of a Chokeberry (<i>Aronia melanocarpa</i> (Michx.) Elliott) Supplementation on Cardiometabolic Outcomes: A Critical Systematic Review and Meta-Analysis of Randomized Controlled Trials.
topicChokeberry Blood Pressure Meta-Analysis
claimRCTs investigating chokeberry supplementation (≥2 weeks) in adults (≥18 years) with or without cardiometabolic risk factors were included.
evidence level1
citationFrumuzachi O (2025)
sourceImpact of a Chokeberry (<i>Aronia melanocarpa</i> (Michx.) Elliott) Supplementation on Cardiometabolic Outcomes: A Critical Systematic Review and Meta-Analysis of Randomized Controlled Trials.
topicChokeberry Blood Pressure Meta-Analysis
claimHeterogeneity was assessed using the I 2 statistic, and risk of bias was evaluated with the Cochrane risk of bias 1 (RoB 1) tool.
evidence level1
citationFrumuzachi O (2025)
sourceImpact of a Chokeberry (<i>Aronia melanocarpa</i> (Michx.) Elliott) Supplementation on Cardiometabolic Outcomes: A Critical Systematic Review and Meta-Analysis of Randomized Controlled Trials.
topicChokeberry Blood Pressure Meta-Analysis
claimBackground/Objectives : Chokeberry ( Aronia melanocarpa (Michx.) Elliott) is a (poly)phenol-rich fruit with purported cardiometabolic benefits.
evidence level1
citationFrumuzachi O (2025)
sourceImpact of a Chokeberry (<i>Aronia melanocarpa</i> (Michx.) Elliott) Supplementation on Cardiometabolic Outcomes: A Critical Systematic Review and Meta-Analysis of Randomized Controlled Trials.